Mortality and Pre‐Hospitalization use of Renin‐Angiotensin System Inhibitors in Hypertensive COVID‐19 Patients

BACKGROUND: There has been significant controversy regarding the effects of pre‐hospitalization use of renin‐angiotensin system (RAS) inhibitors on the prognosis of hypertensive COVID‐19 patients. METHODS AND RESULTS: We retrospectively assessed 2,297 hospitalized COVID‐19 patients at Tongji Hospita...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Chen, Chen, Wang, Feng, Chen, Peng, Jiang, Jiangang, Cui, Guanglin, Zhou, Ning, Moroni, Francesco, Moslehi, Javid J., Ammirati, Enrico, Wang, Dao Wen
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763411/
https://ncbi.nlm.nih.gov/pubmed/32807002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.017736
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados